Aaron Wealth Advisors LLC Novo Cure LTD Transaction History
Aaron Wealth Advisors LLC
- $1.66 Billion
- Q3 2025
A detailed history of Aaron Wealth Advisors LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Aaron Wealth Advisors LLC holds 38,225 shares of NVCR stock, worth $540,119. This represents 0.03% of its overall portfolio holdings.
Number of Shares
38,225Holding current value
$540,119% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
282Shares Held
77.4MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$171 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$152 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$97.6 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$90.2 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$37.8 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.48B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...